MyDay®MiSight® 1 day has the technology found in:
Together, in one new contact lens
Designed to make myopia management easy for your patients₸†2-3,5
Preferred for comfort compared to original MiSight® 1 day‡2
Up to 4 times the oxygen transmissibility of a hydrogel 1-day lens§
Rated Easier to insert compared to original MiSight® 1 day lens†2
Built-in UV blocker¶
Tried, Tested, Proven.**1 ActivControl® Technology:
Works for nearly all children with myopia ∞4,5
Post treatment, any further myopic progression occurs at age-expected rates ≠7,8
Cuts the worsening of myopia by approximately half ±5,6
The 7-year clinical trial of ActivControl® Technology is the longest-running soft contact lens study among children ††
Designed to be loved by young people. Easy to Use & Wear.◊1,4,9-10
100% of children were happy with the overall comfort of MyDay® MiSight® 1 day contact lenses‡‡9
Children achieved better than 6/6 (20/20) visual acuity∆9
More children rate these lenses as easier to insert than original MiSight® 1 day†9
Product Details
INDICATIONS: The MyDay MiSight 1 day (stenfilcon A) Soft Contact Lenses for Myopia Control are indicated for the correction of ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes in powers from -20.00D to +2.00 diopters. The lenses may be worn by persons who exhibit astigmatism of -2.00 diopters or less that does not interfere with visual acuity. MyDay MiSight 1 day (stenfilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study of MiSight 1 day (omafilcon A) containing identical dual focus optics to that of MyDay MiSight 1 day (stenfilcon A). Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MyDay MiSight 1 day (stenfilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
* Proven to slow myopia progression in children compared to a single vision 1-day lens over a 3-year period.
₸ In clinical study, mean weekday wear time increased from 12.8 hours/day at 6-months to 13.9 hours/day at 6-years with a mean of >6.5 days/week for MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.
† 94% vs. 81% after 1 week of daily wear, p=NS.
‡ 19% vs. 3% after 1 week of daily wear, p=0.02.
§ Based on manufacturers published data. MyDay® MiSight® 1 day has Dk/t of 100. Compared to the original MiSight® 1 day (Dk/t 28), NaturalVue Multifocal 1 Day (Dk/t 25).
¶ WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing googles or sunglasses because they do not completely cover the eye and surrounding area. Persons should continue to use their protective UV-absorbing eyewear as directed.
∞ 90% of myopic eyes respond to treatment with MiSight® 1 day (ages 11-15 at start of wear, n=90), which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.
± Using measured and modeled data, pooled across ages (8-17), myopia progression was slowed by an average of approximately 50% with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.
≠ On average, for children aged 8-15 at initiation of treatment, there was no indication that accumulated treatment effect gained following 3 or 6 years of MiSight® 1 day wear was lost during a 12-month cessation study. Instead, eye growth reverted to expected, age average myopic progression rates.
†† MyDay® MiSight® 1 day contact lenses use the same ActivControl® Technology as the original MiSight® 1 day.
◊ Based on adherence to replacement schedule, lens handling, comfort, satisfaction, vision quality, and visual acuity findings.
‡‡ Clinical study participants at the 1-week visit. 38% rated very happy, 53% rated happy, 9% rated slightly happy with overall comfort satisfaction.
∆ In a clinical study, VA (LogMAR) ≥ 6/6 (20/20) for both study visits (dispense and 1 week).
References:
1. Chamberlain P et al A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
2. Woods J et al. Ocular health of children wearing daily disposable contact lenses over a 6-year period. CLAE 2021 Aug;44(4):101391.
3. CVI data on file 2025. Prospective, 1-week, double masked, randomized, bilateral crossover study with MiSight® 1 day and MyDay® MiSight® 1 day. N=32 subjects aged 8-18 years.
4. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. Optom Vis Sci. 2022 Mar 1;99(3):204-212.
5. CVI data on file, 2025.
6. Arumugam B, Bradley A, Hammond D, Chamberlain P. Modelling Age Effects of Myopia Progression for the MiSight® 1 day Clinical Trial. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2333.
7. Hammond D, Arumugam B, et al. Myopia Control Treatment Gains are Retained after Termination of Dual-focus Contact Lens Wear with no Evidence of a Rebound Effect. OVS 2021;98:E-abstract 215130.
8. Chamberlain, P et al. Eye growth and myopia progression following cessation of myopia control therapy with a dual-focus soft contact lens. OVS 2025. In Press.
9. CVI data on file 2025. Prospective, 1-week, double masked, bilateral study with MyDay® MiSight® 1 day. N=32 subjects aged 8-18 years.
10.Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight® 1 day 7 year findings. OVS 2021;98:E-abstract 210049.